192 related articles for article (PubMed ID: 29953011)
1. Prevalence and factors associated with nonalcoholic fatty pancreas disease and its severity in China.
Weng S; Zhou J; Chen X; Sun Y; Mao Z; Chai K
Medicine (Baltimore); 2018 Jun; 97(26):e11293. PubMed ID: 29953011
[TBL] [Abstract][Full Text] [Related]
2. Transabdominal ultrasonography of the pancreas is superior to that of the liver for detection of ectopic fat deposits resulting from metabolic syndrome.
Li S; Su L; Lv G; Zhao W; Chen J
Medicine (Baltimore); 2017 Sep; 96(37):e8060. PubMed ID: 28906401
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Pancreas Disease: Role in Metabolic Syndrome, "Prediabetes," Diabetes and Atherosclerosis.
Filippatos TD; Alexakis K; Mavrikaki V; Mikhailidis DP
Dig Dis Sci; 2022 Jan; 67(1):26-41. PubMed ID: 33469809
[TBL] [Abstract][Full Text] [Related]
4. Ectopic fat deposition and its related abnormalities of lipid metabolism followed by nonalcoholic fatty pancreas.
Chen Y; Zhang P; Lv S; Su X; Du Y; Xu C; Jin Z
Endosc Ultrasound; 2022; 11(5):407-413. PubMed ID: 35848656
[TBL] [Abstract][Full Text] [Related]
5. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
[TBL] [Abstract][Full Text] [Related]
6. ASSOCIATION BETWEEN NONALCOHOLIC FATTY PANCREATIC DISEASE AND TRIGLYCERIDE/GLUCOSE INDEX.
Andrade LJO; Oliveira LM; Bittencourt AMV; Baptista GM; Oliveira GCM
Arq Gastroenterol; 2023; 60(3):345-349. PubMed ID: 37792764
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.
Della Corte C; Mosca A; Majo F; Lucidi V; Panera N; Giglioni E; Monti L; Stronati L; Alisi A; Nobili V
Clin Endocrinol (Oxf); 2015 Nov; 83(5):656-62. PubMed ID: 26201937
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Non-Alcoholic Fatty Pancreas Disease (NAFPD) and its risk factors among adult medical check-up patients in a private hospital: a large cross sectional study.
Lesmana CR; Pakasi LS; Inggriani S; Aidawati ML; Lesmana LA
BMC Gastroenterol; 2015 Dec; 15():174. PubMed ID: 26652175
[TBL] [Abstract][Full Text] [Related]
9. [NON-ALCOHOLIC FATTY PANCREATIC DISEASE (NAFPD) AND THE METABOLIC SYNDROME: INITIATING FACTOR OR ADDITIONAL COMPONENT?].
Grigorieva IN; Efimova OV; Tov NL; Suvorova TS
Eksp Klin Gastroenterol; 2015; (9):86-91. PubMed ID: 26931016
[TBL] [Abstract][Full Text] [Related]
10. Study of non-alcoholic fatty pancreatic disease among the Egyptian population and the value of serum fatty acid binding protein-1 (FABP-1) as a non-invasive biomarker.
Okasha HH; Hegazy MA; Shaker O; Elfatah YA; El-Sawy SS; Abdelfatah D; Abdellatef A
Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102364. PubMed ID: 38788255
[TBL] [Abstract][Full Text] [Related]
11. Nonalcoholic Fatty Pancreas Disease: Clinical Consequences.
Dite P; Blaho M; Bojkova M; Jabandziev P; Kunovsky L
Dig Dis; 2020; 38(2):143-149. PubMed ID: 31865317
[TBL] [Abstract][Full Text] [Related]
12. Non-alcoholic fatty pancreas disease - practices for clinicians.
Pinte L; Balaban DV; Băicuş C; Jinga M
Rom J Intern Med; 2019 Sep; 57(3):209-219. PubMed ID: 30901317
[TBL] [Abstract][Full Text] [Related]
13. Impact of non-alcoholic fatty pancreas disease on glucose metabolism.
Yu TY; Wang CY
J Diabetes Investig; 2017 Nov; 8(6):735-747. PubMed ID: 28371475
[TBL] [Abstract][Full Text] [Related]
14. [Incretins-adipocytokines interactions in type 2 diabetic subjects with or without non-alcoholic fatty liver disease: interest of GLP-1 (glucagon-like peptide-1) as a modulating biomarker].
Chellali S; Boudiba A; Griene L; Koceir EA
Ann Biol Clin (Paris); 2019 Jun; 77(3):261-271. PubMed ID: 30998190
[TBL] [Abstract][Full Text] [Related]
15. Type 2 diabetes: Does pancreatic fat really matter?
Guglielmi V; Sbraccia P
Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 28984071
[TBL] [Abstract][Full Text] [Related]
16. Ectopic fat accumulation in the pancreas and its clinical relevance: A systematic review, meta-analysis, and meta-regression.
Singh RG; Yoon HD; Wu LM; Lu J; Plank LD; Petrov MS
Metabolism; 2017 Apr; 69():1-13. PubMed ID: 28285638
[TBL] [Abstract][Full Text] [Related]
17. Enigmatic ectopic fat: prevalence of nonalcoholic fatty pancreas disease and its associated factors in a Chinese population.
Wang CY; Ou HY; Chen MF; Chang TC; Chang CJ
J Am Heart Assoc; 2014 Feb; 3(1):e000297. PubMed ID: 24572250
[TBL] [Abstract][Full Text] [Related]
18. In New-Onset Diabetes Mellitus, Metformin Reduces Fat Accumulation in the Liver, But Not in the Pancreas or Pericardium.
Zsóri G; Illés D; Ivány E; Kosár K; Holzinger G; Tajti M; Pálinkás E; Szabovik G; Nagy A; Palkó A; Czakó L
Metab Syndr Relat Disord; 2019 Jun; 17(5):289-295. PubMed ID: 31013454
[No Abstract] [Full Text] [Related]
19. The association between nonalcoholic fatty pancreas disease and diabetes.
Ou HY; Wang CY; Yang YC; Chen MF; Chang CJ
PLoS One; 2013; 8(5):e62561. PubMed ID: 23671610
[TBL] [Abstract][Full Text] [Related]
20. [Lipid accumulation in the pancreas: clinical significance of NAFPD (non-alcoholic fatty pancreas disease)].
Jermendy G
Orv Hetil; 2022 Oct; 163(44):1735-1742. PubMed ID: 36309887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
